Three-weekly docetaxel with prednisone is feasible for japanese patients with hormone-refractory prostate cancer: A retrospective comparative study with weekly docetaxel alone

Toru Shimazui, Koji Kawai, Naoto Miyanaga, Takahiro Kojima, Noritoshi Sekido, Shiro Hinotsu, Takehiro Oikawa, Akira Joraku, Hideyuki Akaza

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Three-weekly docetaxel with prednisone is feasible for japanese patients with hormone-refractory prostate cancer: A retrospective comparative study with weekly docetaxel alone'. Together they form a unique fingerprint.

Medicine & Life Sciences